Pharmacokinetics of ertapenem in burns patients

International Journal of Antimicrobial Agents

Volumn 42, Issue 1, 2013, Pages 48-52

  Dailly, E ^a,b   Arnould, J F ^a   Fraissinet, F ^a   Naux, E ^a   Letard De La Bouraliere M A ^a   Bouquie R ^a,c   Deslandes, G ^a   Jolliet, P ^a,c   Le Floch, R ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Universite de Nantes   (France)

Author keywords

Burns; Ertapenem; Pharmacokinetics

Indexed keywords

ERTAPENEM;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY SURFACE; BURN; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPOALBUMINEMIA; MALE; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; BURNS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PLASMA; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84879233110     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.02.021     Document Type: Article

References (14)

1. I. Odenholt Ertapenem: a new carbapenem Expert Opin Investig Drugs 10 2001 1157 1166
2. P.M. Shah, and R.D. Isaacs Ertapenem, the first of a new group of carbapenems J Antimicrob Chemother 52 2003 538 542
3. D.E. Nix, A.K. Majumdar, and M.J. DiNubile Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians J Antimicrob Chemother 53 Suppl. 2 2004 ii23 ii28
4. U. Jaehde, and F. Sörgel Clinical pharmacokinetics in patients with burns Clin Pharmacokinet 29 1995 15 28
5. M.J. Weinbren Pharmacokinetics of antibiotics in burn patients J Antimicrob Chemother 44 1999 319 327
6. A.K. Majumdar, D.G. Musson, K.L. Birk, C.J. Kitchen, S. Holland, and J. McCrea Pharmacokinetics of ertapenem in healthy young volunteers Antimicrob Agents Chemother 46 2002 3506 3511
7. B.A. Boucher, W.L. Hickerson, D.A. Kuhl, A.M. Bombassaro, and G.S. Jaresko Imipenem pharmacokinetics in patients with burns Clin Pharmacol Ther 48 1990 130 137
8. R.A. Walstad, L. Aanderud, and E. Thurmann-Nielsen Pharmacokinetics and tissue concentrations of ceftazidime in burn patients Eur J Clin Pharmacol 35 1988 543 549
9. E. Dailly, R. Bouquié, G. Deslandes, P. Jolliet, and R. Le Floch A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study J Chromatogr B Analyt Technol Biomed Life Sci 879 2011 1137 1142
10. D.G. Musson, K.L. Birk, C.J. Kitchen, J. Zhang, J.Y. Hsieh, and W. Fang Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma J Chromatogr B Analyt Technol Biomed Life Sci 783 2003 1 9
11. O. Burkhardt, V. Kumar, D. Katterwe, J. Majcher-Peszynska, B. Drewelow, and H. Derendorf Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration J Antimicrob Chemother 59 2007 277 284
12. A.J. Brink, G.A. Richards, V. Schillack, S. Kiem, and J. Schentag Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis Int J Antimicrob Agents 33 2009 432 436
13. M. Ulldemolins, J.A. Roberts, J. Rello, D.L. Paterson, and J. Lipman The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients Clin Pharmacokinet 50 2011 99 110
14. Société Française d'Anesthésie Réanimation. Utilisation des solutions d'albumine humaine en anesthésie-réanimation chirurgicale de l'adulte (CC 1995). http://www.sfar.org/article/266/utilisation-des-solutions-d-albumine-humaine-en- anesthesie-reanimation-chirurgicale-de-l-adulte-cc-1995 [accessed 12.03.13].